Philip Home

14.3k citations
220 papers · 10.6k · 3 hit papers · h-index 50

Impact in

    • Diabetes Management and Research
    • Diabetes Treatment and Management
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients
    • Diabetes, Cardiovascular Risks, and Lipoproteins

Papers in

    • Diabetes Management and Research 108
    • Diabetes Treatment and Management 57
    • Diabetes, Cardiovascular Risks, and Lipoproteins 22
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 15
    • Pancreatic function and diabetes 33

Philip Home

212 papers receiving 10.1k citations

Philip Home's Hit Papers

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial 2009 · 1.0k citations
1.0k0+6+13Years since publication2505007501000

Peers

Philip Home
Comparison fields: 5 of 151
  • Endocrinology, Diabetes and Metabolism 6.5k
  • Transplantation 147
  • Surgery 2.2k
  • Genetics 1.1k
  • Physiology 775
Replace Eberhard Standl with:
Eberhard Standl Germany
David R. Owens United Kingdom
Giatgen A. Spinas Switzerland
Saul Genuth United States
Janet B. McGill United States
Ramón Gomis Spain
Giancarlo Viberti United Kingdom
Guntram Schernthaner Austria
Alan J. Garber United States
Andrzej S. Królewski United States
Philip Home relative to Eberhard Standl Germany Eberhard Standl's profile →
Citations per field
00.5×1.6×
Eberhard Standl · 1×
Citations per year

Countries citing papers authored by Philip Home

Since Specialization
Citations

This map shows the geographic impact of Philip Home's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Home with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Home more than expected).

Fields of papers citing papers by Philip Home

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Home. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Home. The network helps show where Philip Home may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Home, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Home Line = papers co-authored together Philip Home links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Hit paper breakdown →
20091011
2
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
Hit paper breakdown →
2007560
3
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes
Hit paper breakdown →
2006500
4 2010351
5 2008343
6 2014278
7 2004266
8 2013249
9 2015234
10 2004208
11 1998199
12 2000192
13 2005180
14 2015169
15 2012155
16 1993146
17 2015144
18 2002143
19 2013129
20 2011127

About Philip Home

Philip Home is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Physiology and Genetics, having authored 220 papers that have together received 10.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (108 papers), Diabetes Treatment and Management (57 papers), Pancreatic function and diabetes (33 papers), Diabetes and associated disorders (22 papers), Metabolism, Diabetes, and Cancer (22 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (15 papers) and Diet and metabolism studies (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.5k citations), Transplantation (147 citations), Surgery (2.2k citations), Genetics (1.1k citations) and Physiology (775 citations). Philip Home has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Nigel C. Jones, John J.V. McMurray, Ramón Gomis, Stuart Pocock, Henning Beck‐Nielsen, M Hanefeld, Matthew C. Riddle, Latika Sibal, Anna Lindholm Olinder and Michel Komajda. Their work appears in journals such as Diabetes Care, Diabetic Medicine, Diabetes Research and Clinical Practice, Diabetes Obesity and Metabolism and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact